Oncolytics Biotech Inc. (ONCY): Price and Financial Metrics
ONCY Price/Volume Stats
| Current price | $1.00 | 52-week high | $1.75 |
| Prev. close | $1.06 | 52-week low | $0.84 |
| Day low | $0.99 | Volume | 278,100 |
| Day high | $1.09 | Avg. volume | 328,455 |
| 50-day MA | $1.09 | Dividend yield | N/A |
| 200-day MA | $1.06 | Market Cap | 76.96M |
ONCY Stock Price Chart Interactive Chart >
Oncolytics Biotech Inc. (ONCY) Company Bio
Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.
ONCY Price Returns
| 1-mo | -21.26% |
| 3-mo | 1.01% |
| 6-mo | -8.26% |
| 1-year | -37.50% |
| 3-year | -46.24% |
| 5-year | -3.85% |
| YTD | -25.93% |
| 2023 | -17.18% |
| 2022 | 17.27% |
| 2021 | -41.60% |
| 2020 | -50.00% |
| 2019 | 162.98% |
Loading social stream, please wait...